Kangji Medical’s privatization scheme approved, delisting from HKEX imminent

Kangji Medical Holdings Limited announced the successful approval of its privatization by scheme of arrangement. At a Court Meeting and EGM held on Monday, November 10, 2025, resolutions to approve the Scheme and a Special Deal were passed with significant majorities. The total number of shares in issue was 1,207,994,000, with 303,616,000 shares entitled to be voted by independent shareholders.

The scheme is expected to become effective on Friday, December 5, 2025 (Cayman Islands time). The last day for trading Kangji Medical shares was Tuesday, November 11, 2025, and the withdrawal of listing from the Stock Exchange is scheduled for 4:00 p.m. on Tuesday, December 9, 2025. Cheques for cash payments will be despatched on or before Tuesday, December 16, 2025.

J.P. Morgan Securities PLC, an associate connected with the Offeror, reported closing out various derivative contracts related to Kangji Medical Holdings shares on November 7, 2025, at a reference price of $9.0400 or $9.0424. These dealings resulted in total amounts paid/received ranging from $9,042.4000 to $2,024,963.5800, adjusting its resultant balance of underlying shares from 9,592,343 down to 9,201,843. J.P. Morgan Securities PLC is ultimately owned by JPMorgan Chase & Co.